CELLGATE
Progen Pharmaceuticals, Inc. develops pharmaceutical products for the treatment of anti-proliferation and cancer therapeutics. The company's products are also used for the treatment of various diseases, including age-related macular degeneration, infectious diseases, inflammatory diseases, and vascular hyperplasia. Progen Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Redwood City, California. Progen Pharmaceuticals, Inc. was formerly known as CellGate, Inc. As a result of the acquisition of Cellgate, Inc. by Progen Pharmaceuticals Limited, Cellgate's name was changed. As of February 7, 2008, Progen Pharmaceuticals, Inc. operates as a subsidiary of Progen Pharmaceuticals Limited (ASX: PGL).
CELLGATE
Industry:
Biotechnology Health Care Medical
Founded:
1998-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.cellgate.com
Total Employee:
1+
Status:
Active
Contact:
650-610-7800
Total Funding:
72.9 M USD
Technology used in webpage:
SPF Nginx DOSarrest Uniregistry
Current Advisors List
Founder
Investors List
New Enterprise Associates
New Enterprise Associates investment in Series E - CellGate
Sprout Group
Sprout Group investment in Series E - CellGate
HealthCare Ventures
HealthCare Ventures investment in Series E - CellGate
HealthCare Ventures
HealthCare Ventures investment in Series D - CellGate
New Enterprise Associates
New Enterprise Associates investment in Series D - CellGate
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series D - CellGate
HealthCare Ventures
HealthCare Ventures investment in Series C - CellGate
New Enterprise Associates
New Enterprise Associates investment in Series C - CellGate
Official Site Inspections
http://www.cellgate.com
- Host name: 104.247.81.54
- IP address: 104.247.81.54
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
